Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement
This comparative study of the review models and regulatory timelines of countries participating in the ECOWAS-MRH initiative has highlighted both the similarities among the authorities and also the differences to be addressed in order to improve upon the regulatory systems in these countries.
Authors
- Seth Kwaku Seaneke
- Mercy Owusu-Asante
- D. Lamboni (ORCID: https://orcid.org/0009-0000-4249-529X)
- Sheku Mansaray
- Sam Salek (ORCID: https://orcid.org/0000-0002-4612-5699)
- Stuart Walker (ORCID: https://orcid.org/0000-0002-7688-5306)
- James P. Komeh
- Moji Christianah Adeyeye (ORCID: https://orcid.org/0000-0003-3808-3166)
- Delese Mimi Darko
- Oumy Kalsoum Ndao
- Rokhaya Ndiaye Kande
- Maheza Agba
- Aminata Nacoulma
- Oula Ibrahim Olivier Traore
- Abayomi Akinyemi
- Coulibaly Assane
- Clarisse Épse Kaul Meledje Clamoungou
Institutions
- University of Hertfordshire (GB)
- Centre for Innovation in Regulatory Science (GB)
- University of Science and Technology of Togo (TG)
- Togolese Ministry of Health (TG)
- National Agency for the Control of AIDS (NG)
- Sierra Leone Agricultural Research Institute (SL)
- University of Lomé (TG)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-07-14
- DOI
- https://doi.org/10.3389/fmed.2025.1587761
- Citations
- 1
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Bill and Melinda Gates Foundation